2015
DOI: 10.3109/10253890.2015.1025044
|View full text |Cite
|
Sign up to set email alerts
|

Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice

Abstract: Acute restraint stress (ARS) for 3 hours causes CORT elevation in venous blood, which is accompanied by Fos up-regulation in the paraventricular nucleus (PVN) of male C57BL/6 mice. CORT elevation by ARS is attenuated in PACAP-deficient mice, but unaffected in PAC1-deficient mice. Correspondingly, Fos up-regulation by ARS is greatly attenuated in PACAP-deficient mice, but much less so in PAC1-deficient animals. We noted that both PACAP- and PAC1-deficiency greatly attenuate CORT elevation after ARS when CORT me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
41
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 55 publications
(47 citation statements)
references
References 28 publications
3
41
0
Order By: Relevance
“…(Nanopoulos et al, 1982;Bagdy et al, 2000;Lin, 2015). 957 In the next step, we quantified the number of 5-HT- The CVMS model (Willner, 2005) which fits with the findings of Mustafa et al (2015). Imipra-1017 mine seems to reduce the bodyweight gain in non-1018 stressed WT mice, which phenomenon was observed 1019 by other laboratories both in rats (Lewis et al, 1983) 1020 and mice (Zhao et al, 2015).…”
mentioning
confidence: 66%
“…(Nanopoulos et al, 1982;Bagdy et al, 2000;Lin, 2015). 957 In the next step, we quantified the number of 5-HT- The CVMS model (Willner, 2005) which fits with the findings of Mustafa et al (2015). Imipra-1017 mine seems to reduce the bodyweight gain in non-1018 stressed WT mice, which phenomenon was observed 1019 by other laboratories both in rats (Lewis et al, 1983) 1020 and mice (Zhao et al, 2015).…”
mentioning
confidence: 66%
“…A translational issue that is re-cast by our data is the potential mode of gene therapeutic delivery of PACAP, or closely related peptide analogs, in vivo , in the context of neuroprotection [24], tumor suppression [30], treatment of stress-related affective disorders [29], PTSD [10], and migraine [1]. Therapeutic application of neuropeptides for these and other disorders is highly dependent on the need for amidation, since the latter can occur only in secretory granule-releasing tissues [13, 14], and cannot be programmed within DNA-based expression vectors if the latter are expressed in non-neuroendocrine tissues.…”
Section: Discussionmentioning
confidence: 99%
“…is attenuated in PACAP-deficient mice, and that chronic restraint stress, with as little as 2 hr of restraint stress daily, triggers hypophagia, measured by weight loss consequent to decreased food consumption, throughout a three-week period (Mustafa et al, 2015). Furthermore, the chronic effects of PACAP deficiency were phenocopied in mice deficient in expression of the PAC1 PACAP receptor, indicating a potential therapeutic target for blunting the maladaptive behaviors emergent during chronic stress (Mustafa et al, 2015). Here, we have administered restraint stress for 1, 2 or 3 hours over a period of 7 days, and monitored CORT elevation as an index of HPA axis (endocrine) activation, and decreased food consumption as an index of stress-dependent behavioral alteration.…”
Section: Introductionmentioning
confidence: 99%